Morphine manifesto
10th February 2012
Leading organisations in the UK and around the world are supporting the morphine manifesto, which calls for an end to the unethical practice of promoting access to expensive opioid analgesics without also making low cost immediate release oral morphine available. The manifesto is appealing to governments, healthcare institutions, and the pharmaceutical industry to assure the accessibility of immediate release morphine to patients in need at a cost that the individual and community can afford. For more information and to sign the manifesto see below.
Recent news
- Die zweite Ausgabe des APM Newsletter ist fertig.
- Prescribing and mixing controlled drugs - changes
- Tolvaptan: over-rapid increase in serum sodium and risk of serious neurological events
- Risks of hypomagnesaemia and increased risk of fracture with long-term PPI use
- NICE updated infection control guidelines
- MHRA alert for co-codamol 8/500 tablets
- NPSA RRR: Harm from flushing of nasogastric tubes before confirmation of placement
- Capsaicin patch license extension application withdrawn
- Wir freuen uns, Ihnen den ersten APM Newsletter vorstellen zu dürfen
- Alert update on Prednisolone e/c recalled from Teva
News archive
- 2012
- 2011
- 2010
- 2009
- 2008
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000